FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290973876> ?p ?o ?g. }

• W4290973876 endingPage "284" @default.
• W4290973876 startingPage "276" @default.
• W4290973876 abstract "Background The addition of either docetaxel or an androgen receptor signalling pathway inhibitor (ARSi) to androgen-deprivation therapy (ADT) has become the standard of care for metastatic castration-sensitive prostate cancer (mCSPC) patients. Recent phase III data support even greater survival impact of a triplet regimen with ADT plus docetaxel plus an ARSi (abiraterone or darolutamide) compared to ADT plus docetaxel. Objective To evaluate whether the addition of an ARSi to ADT improves outcomes of mCSPC patients treated with docetaxel. Methods We searched MEDLINE/PubMed, the Cochrane Library, and ASCO Meeting abstracts for randomised clinical trials (RCTs) testing the combination of ARSi + ADT in mCSPC men who received docetaxel. Data extraction was conducted according to the PRISMA statement. Summary hazard ratio (HR) was calculated using random- or fixed-effects models. The statistical analyses were performed with RevMan software (v.5.2.3). Results Five RCTs were selected. Triplet therapy improved overall survival (OS) compared to ADT + docetaxel in mCSPC patients (HR = 0.73; p < 0.00001). This intensified strategy maintained the OS benefit when the ARSi was administered concomitant to chemotherapy (HR = 0.72; p < 0.00001), but no statistical effect was detected if the ARSi was sequential to docetaxel (p = 0.44). Moreover, in the subgroup of men with de novo mCSPC, triplets significantly improved OS (HR = 0.72, p < 0.0001). The lack of access to raw data was the main limit of our analysis. Conclusion Our results support a clear survival advantage of adding an ARSi to ADT in mCSPC patients treated with docetaxel, mainly when the ARSi was administered concomitantly to chemotherapy and in the subgroup of de novo mCSPC." @default.
• W4290973876 created "2022-08-13" @default.
• W4290973876 creator A5004985848 @default.
• W4290973876 creator A5007779528 @default.
• W4290973876 creator A5028571081 @default.
• W4290973876 creator A5050215401 @default.
• W4290973876 creator A5065945024 @default.
• W4290973876 creator A5082338484 @default.
• W4290973876 date "2022-09-01" @default.
• W4290973876 modified "2023-10-07" @default.
• W4290973876 title "Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis" @default.
• W4290973876 cites W1986215651 @default.
• W4290973876 cites W2123629153 @default.
• W4290973876 cites W2150865892 @default.
• W4290973876 cites W2156098321 @default.
• W4290973876 cites W2620746860 @default.
• W4290973876 cites W2783782279 @default.
• W4290973876 cites W2787804990 @default.
• W4290973876 cites W2795813205 @default.
• W4290973876 cites W2802053856 @default.
• W4290973876 cites W2885761289 @default.
• W4290973876 cites W2889549181 @default.
• W4290973876 cites W2890444045 @default.
• W4290973876 cites W2938589827 @default.
• W4290973876 cites W2947893479 @default.
• W4290973876 cites W2949516084 @default.
• W4290973876 cites W2963794755 @default.
• W4290973876 cites W2975895768 @default.
• W4290973876 cites W2991792334 @default.
• W4290973876 cites W3041536059 @default.
• W4290973876 cites W3128646645 @default.
• W4290973876 cites W3158318954 @default.
• W4290973876 cites W3164510972 @default.
• W4290973876 cites W3191534679 @default.
• W4290973876 cites W4200390731 @default.
• W4290973876 cites W4200484394 @default.
• W4290973876 cites W4213196409 @default.
• W4290973876 cites W4221135453 @default.
• W4290973876 cites W4223443163 @default.
• W4290973876 cites W4288061296 @default.
• W4290973876 doi "https://doi.org/10.1016/j.ejca.2022.07.011" @default.
• W4290973876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35964470" @default.
• W4290973876 hasPublicationYear "2022" @default.
• W4290973876 type Work @default.
• W4290973876 citedByCount "8" @default.
• W4290973876 countsByYear W42909738762022 @default.
• W4290973876 countsByYear W42909738762023 @default.
• W4290973876 crossrefType "journal-article" @default.
• W4290973876 hasAuthorship W4290973876A5004985848 @default.
• W4290973876 hasAuthorship W4290973876A5007779528 @default.
• W4290973876 hasAuthorship W4290973876A5028571081 @default.
• W4290973876 hasAuthorship W4290973876A5050215401 @default.
• W4290973876 hasAuthorship W4290973876A5065945024 @default.
• W4290973876 hasAuthorship W4290973876A5082338484 @default.
• W4290973876 hasConcept C121608353 @default.
• W4290973876 hasConcept C126322002 @default.
• W4290973876 hasConcept C143998085 @default.
• W4290973876 hasConcept C187960798 @default.
• W4290973876 hasConcept C207103383 @default.
• W4290973876 hasConcept C2777899217 @default.
• W4290973876 hasConcept C2780192828 @default.
• W4290973876 hasConcept C2781190966 @default.
• W4290973876 hasConcept C2781413609 @default.
• W4290973876 hasConcept C44249647 @default.
• W4290973876 hasConcept C535046627 @default.
• W4290973876 hasConcept C71924100 @default.
• W4290973876 hasConcept C95190672 @default.
• W4290973876 hasConceptScore W4290973876C121608353 @default.
• W4290973876 hasConceptScore W4290973876C126322002 @default.
• W4290973876 hasConceptScore W4290973876C143998085 @default.
• W4290973876 hasConceptScore W4290973876C187960798 @default.
• W4290973876 hasConceptScore W4290973876C207103383 @default.
• W4290973876 hasConceptScore W4290973876C2777899217 @default.
• W4290973876 hasConceptScore W4290973876C2780192828 @default.
• W4290973876 hasConceptScore W4290973876C2781190966 @default.
• W4290973876 hasConceptScore W4290973876C2781413609 @default.
• W4290973876 hasConceptScore W4290973876C44249647 @default.
• W4290973876 hasConceptScore W4290973876C535046627 @default.
• W4290973876 hasConceptScore W4290973876C71924100 @default.
• W4290973876 hasConceptScore W4290973876C95190672 @default.
• W4290973876 hasLocation W42909738761 @default.
• W4290973876 hasLocation W42909738762 @default.
• W4290973876 hasOpenAccess W4290973876 @default.
• W4290973876 hasPrimaryLocation W42909738761 @default.
• W4290973876 hasRelatedWork W2081815287 @default.
• W4290973876 hasRelatedWork W2129685713 @default.
• W4290973876 hasRelatedWork W2139614539 @default.
• W4290973876 hasRelatedWork W2201793188 @default.
• W4290973876 hasRelatedWork W236807388 @default.
• W4290973876 hasRelatedWork W2515537233 @default.
• W4290973876 hasRelatedWork W2591225277 @default.
• W4290973876 hasRelatedWork W2947088833 @default.
• W4290973876 hasRelatedWork W3095184244 @default.
• W4290973876 hasRelatedWork W3147275309 @default.
• W4290973876 hasVolume "173" @default.
• W4290973876 isParatext "false" @default.
• W4290973876 isRetracted "false" @default.
• W4290973876 workType "article" @default.